ARCT-2601 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

5,749 results for “ARCT-2601”

Trials

View all 4295 →

ARCT-2301 Phase III Study

850 participants

A Trial Evaluating the Safety and Immunogenicity of 3 COVID-19 SARS-CoV-2 RNA Vaccines in Healthy Adults

72 participants · First posted Sep 8, 2021

The ARCT-154 Self-Amplifying RNA Vaccine Efficacy Study (ARCT-154-01)

19,474 participants · First posted Aug 19, 2021

Drugs

View all 1192 →

ARCT-2301

ARCT-021

ARCT-165

Organizations

View all 11 →

Arch Biopartners Inc.

Canada

Arch Therapeutics, Inc.

United States

ARCA biopharma, Inc.

United States

News

View all 251 →

Arcturus Reports Interim Phase 2 ARCT-810 Data in OTC Deficiency, Unveils LUNAR 2.0 Delivery Platform

Arcturus Therapeutics' Inhaled mRNA Therapy ARCT-032 Shows Mixed Results in Phase 2 Cystic Fibrosis Trial

Arcturus Therapeutics to Present Phase 2 Data for ARCT-810 mRNA Therapy in Rare Genetic Disorder

Page 1 of 575